Neurologic manifestations associated with a coronavirus disease 2019 (COVID‐19)
diagnosis are common and often occur in severe and critically ill patients. In these patients …

Purpose Severe acute respiratory syndrome coronavirus 2 is the virus resulting in COVID-19
infections in nearly 4.3 million Americans with COVID-19 in the United States as of July 29 …

In December 2019, a highly pathogenic and often fatal virus emerged in Wuhan, China (Q.
Li et al. 2020). By 2020, it had spread to Europe, North America, and nearly 120 countries …

Coronavirus disease 2019 (COVID-19) requires admission to intensive care (ICU) for the
management of acute respiratory distress syndrome in about 5% of cases. Although our …

Respiratory and neurological complications in patients in various stages of COVID-19
emphasize the role of speech-language pathologists in the assessment and management of …

Background The COVID-19 disease frequently causes neurological symptoms. Critically ill
patients often require neurorehabilitation for manifestations like intensive care unit (ICU) …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the resulting
coronavirus disease 2019 (COVID-19) has caused a pandemic. At the time of writing, more …

Abstract Purpose of Review Aphasia is an acquired neurological language disorder after
brain damages. Persons with aphasia (PWA) are more susceptible to behavioral and …

From the start of the COVID-19 outbreak, an increasing amount of scientific literature
focused on epidemiology, pathophysiology and, especially, on treatment in the acute phase …

Patients with coronavirus disease 2019 (COVID-19) often develop acute respiratory failure
and acute respiratory distress syndrome (ARDS) that requires intensive care unit (ICU) …